HOME >> BIOLOGY >> NEWS
UNC awarded $5 million NIH grant to explore disease that inflames blood vessels

activate normal neutrophils to cause tissue damage, and exactly how the damage to small blood vessels occurs remain unclear.

"These are the big questions we'll explore," Falk said. "We also want to develop appropriate animal models for this human disease. We'll also study differences in the ability of patients' leukocytes when compared to normal individuals to do damage. And then there's a big question of whether certain environmental toxins cause the disease."

Falk points out that the research will involve molecular biology and cell biology studies of human blood - including antibodies and leukocytes - a series of animal model experiments, and detailed environmental exposure investigation.

"The disease may have a genetic component, an environmental component and probably an infectious disease component," he said

A member of the UNC Lineberger Comprehensive Cancer Center, the kidney specialist notes that therapy for the disease is about the same as it was 20 years ago. Patients may receive several medications, including steroids intravenously or in pill form. Other powerful and toxic drugs, such as prednisone and the cancer chemotherapies cyclophosphamide and methotrexate, carry a variety of side effects such as nausea, vomiting, bone marrow defects, and GI bleeding.

"Such treatment can be miserable. If we can't figure out the cause of the disease and what allows one to form antibodies, then we'll be stuck with these problematic therapies," Falk said.


'"/>

Contact: Les Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
3-Oct-2000


Page: 1 2

Related biology news :

1. Ecology of infectious diseases grants awarded
2. Joslin President awarded medal from international diabetes organization
3. UNC researchers awarded $8.65 million from National Institute on Aging
4. ESA awarded new SEEDS grant
5. $5.5 million awarded to tree-ring research and climate studies
6. Dartmouth Medical School awarded $9 million grant for genomics research
7. BioTime awarded NIH grant to aid Hetacool development
8. New York microbiologists awarded research grants in antibiotic resistance and lyme disease
9. Researchers awarded $2 million to create high-tech tools for fighting wildfires
10. USC awarded $3.5 million to study DNA enzyme
11. Young scientists awarded for achievements in cancer research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... Md. (PRWEB) , ... November ... ... with Alizée Pathology to form the leading provider of specialized histology, pathology, ... research industries. StageBio was recently created by the mergers of Histo-Scientific Research ...
(Date:11/6/2019)... ... November 06, 2019 , ... In October, Massachusetts stem cell ... patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem ... the treating stem cells. This problem affects all patients receiving stem cell ...
(Date:11/5/2019)... ... November 05, 2019 , ... Dr. ... and restorative dentistry to Seattle, WA, including porcelain veneers , smile makeovers, ... from the University of Washington, Dr. Kopp is passionate about serving her Seattle ...
Breaking Biology News(10 mins):
(Date:10/17/2019)... ... October 16, 2019 , ... ... genetic counseling information, has published a new white paper that explores how frequently ... guidance as to how patients and medical providers can be kept informed as ...
(Date:10/10/2019)... (PRWEB) , ... October 10, 2019 , ... ... , the largest network of clinical research centers in Europe. All Pratia research ... network in Europe to become trained and certified as Virtual Trial Capable and ...
(Date:10/3/2019)... ... October 01, 2019 , ... Cheyenne is a beautiful and strong ... owner, owns and operates Rebel’s Run , which offers riding lessons and trail ... and trail riding guests. Mimi describes her as her “go to horse.” ...
(Date:10/3/2019)... ... ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New England in ... discussed important design factors that currently limit the success of early stage stem cell ... trials, in his talk Dr. Sherley focused on the highly problematic practice ...
Breaking Biology Technology:
Cached News: